Optimer’s Dificid Gets Medicare Payment “Add-On” For Hospital Patients
14:09 EDT 2 Aug 2012 | Elsevier Business Intelligence
In a rare application of its Medicare “new technology add-on payments” policy to drugs, the Centers for Medicare and Medicaid Services announced it will supplement reimbursement to hospitals for the oral antibiotic Deficid and methotrexate toxici..
Original Article: Optimer’s Dificid Gets Medicare Payment “Add-On” For Hospital Patients
More From BioPortfolio on "Optimer’s Dificid Gets Medicare Payment “Add-On” For Hospital Patients"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
